Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shany Blum

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|February 26, 2008
Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotypeShany Blum, Uzi Milman, Chen Shapira, et al.
Diabetes|July 5, 2008
Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotypeRabea Asleh, Shany Blum, Shiri Kalet-Litman, et al.
British Journal of Pharmacology|February 18, 2011
The cardioprotective efficacy of TVP1022 in a rat model of ischaemia/reperfusionOffir Ertracht, Esti Liani, Noa Bachner-Hinenzon, et al.
Journal of the American College of Cardiology|January 9, 2007
Haptoglobin genotype determines myocardial infarct size in diabetic miceShany Blum, Roy Asaf, Julia Guetta, et al.
The New England Journal of Medicine|January 12, 2017
TARGT Gene Therapy Platform for Correction of Anemia in End-Stage Renal DiseaseShany Blum, Nir Shapir, Reem Miari, et al.
Clinical Chemistry and Laboratory Medicine|March 16, 2013
An enzyme linked immunosorbent assay (ELISA) for the determination of the human haptoglobin phenotypeNina S Levy, Moshe Vardi, Shany Blum, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 23, 2007
Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trialUzi Milman, Shany Blum, Chen Shapira, et al.
Journal of the American College of Cardiology|May 28, 2016
Haptoglobin Genotype as a Determinant of Benefit or Harm From Niacin for Participants With DiabetesRabea Asleh, Nina S Levy, Gheorge Doros, et al.
Journal of the American College of Cardiology|January 15, 2013
Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobinLeah E Cahill, Andrew P Levy, Stephanie E Chiuve, et al.
Antioxidants & Redox Signaling|August 8, 2009
Haptoglobin: basic and clinical aspectsAndrew P Levy, Rabea Asleh, Shany Blum, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Arteriosclerosis, Thrombosis, and Vascular Biology|February 26, 2008
Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotypeShany Blum, Uzi Milman, Chen Shapira, et al.
Diabetes|July 5, 2008
Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotypeRabea Asleh, Shany Blum, Shiri Kalet-Litman, et al.
British Journal of Pharmacology|February 18, 2011
The cardioprotective efficacy of TVP1022 in a rat model of ischaemia/reperfusionOffir Ertracht, Esti Liani, Noa Bachner-Hinenzon, et al.
Journal of the American College of Cardiology|January 9, 2007
Haptoglobin genotype determines myocardial infarct size in diabetic miceShany Blum, Roy Asaf, Julia Guetta, et al.
The New England Journal of Medicine|January 12, 2017
TARGT Gene Therapy Platform for Correction of Anemia in End-Stage Renal DiseaseShany Blum, Nir Shapir, Reem Miari, et al.
Clinical Chemistry and Laboratory Medicine|March 16, 2013
An enzyme linked immunosorbent assay (ELISA) for the determination of the human haptoglobin phenotypeNina S Levy, Moshe Vardi, Shany Blum, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 23, 2007
Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trialUzi Milman, Shany Blum, Chen Shapira, et al.
Journal of the American College of Cardiology|May 28, 2016
Haptoglobin Genotype as a Determinant of Benefit or Harm From Niacin for Participants With DiabetesRabea Asleh, Nina S Levy, Gheorge Doros, et al.
Journal of the American College of Cardiology|January 15, 2013
Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobinLeah E Cahill, Andrew P Levy, Stephanie E Chiuve, et al.
Antioxidants & Redox Signaling|August 8, 2009
Haptoglobin: basic and clinical aspectsAndrew P Levy, Rabea Asleh, Shany Blum, et al.
Pageof 4